NCT00131248View on ClinicalTrials.gov

Medical Treatment for Gastroesophageal Reflux Disease (GERD) in Preterm Infants

PHASE3CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Gastroesophageal Reflux
Interventions
DRUG

Metaclopramide

DRUG

Ranitidine

DRUG

placebo

Trial Locations (1)

77030

Memorial Hermann Children's Hospital, Houston

All Listed Sponsors
lead

The University of Texas Health Science Center, Houston

OTHER

NCT00131248 - Medical Treatment for Gastroesophageal Reflux Disease (GERD) in Preterm Infants | Biotech Hunter | Biotech Hunter